Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "Hologic"

107 News Found

Innovative AI software for detection of pancreatic diseases
Digitisation | May 18, 2022

Innovative AI software for detection of pancreatic diseases

As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications


ASPIRE 2022 Congress: Recognising the 'tip of the iceberg' in the complex and chronic effects of endometriosis
Public Health | May 01, 2022

ASPIRE 2022 Congress: Recognising the 'tip of the iceberg' in the complex and chronic effects of endometriosis

It affects up to 10 per cent of women of reproductive age around the world


Signia launches its first hearing impairment store in Delhi
Healthcare | April 17, 2022

Signia launches its first hearing impairment store in Delhi

First of its kind interactive concept store ‘Brilliant Sound Galaxy (BSG)’ in the capital city


Dr. Reddy's and MediCane Health launch medical cannabis in Germany
Biotech | April 03, 2022

Dr. Reddy's and MediCane Health launch medical cannabis in Germany

The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021


Sun Pharma gets exclusive patent licence for Vortioxetine
News | March 30, 2022

Sun Pharma gets exclusive patent licence for Vortioxetine

Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults


Biological Dynamics study demonstrates detection of early-stage cancers
Biotech | March 21, 2022

Biological Dynamics study demonstrates detection of early-stage cancers

In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis


USFDA approves expanded use of Bristol Myers Opdivo
Drug Approval | March 06, 2022

USFDA approves expanded use of Bristol Myers Opdivo

The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer


Bristol Myers Squibb’s application for Opdivo plus chemotherapy receives USFDA priority review
Biotech | March 01, 2022

Bristol Myers Squibb’s application for Opdivo plus chemotherapy receives USFDA priority review

If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.


GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy
Biotech | February 25, 2022

GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy

The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers


Experts highlight positives of yoga in coping with Covid waves
Public Health | January 19, 2022

Experts highlight positives of yoga in coping with Covid waves

Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run